Advertisement

Topics

Two New Italian €500m Funds for Innovative Drugs for Cancer, Hep C

01:21 EDT 29 Jun 2017 | Elsevier Business Intelligence

New medicines for hepatitis C and cancer are among innovative therapies benefiting from two special funds set up by the......

Original Article: Two New Italian €500m Funds for Innovative Drugs for Cancer, Hep C

NEXT ARTICLE

More From BioPortfolio on "Two New Italian €500m Funds for Innovative Drugs for Cancer, Hep C"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Gastroenterology
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...